Concepedia

Andrew Woodland

AW

Statistics

Publications

11

Citations

789

H-Index

11

Active since

2003

Affiliations

University of Dundee(Current)

Drug Discovery Laboratory (Norway)

GlaxoSmithKline (Spain)

Discovery Centre

Medicines for Malaria Venture

Andrew Woodland is an author at University of Dundee specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2003–2018

11

Publications

11

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 465 citations · Full text

, , +14

Identification of Small Molecule Inhibitors of Pre-mRNA Splicing

Andrea Pawellek, Stuart P. McElroy, Timur R. Samatov et al. · Journal of Biological Chemistry · 2014 · 74 citations · Full text

, , +15

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Michael G. Thomas, Manu De Rycker, Myriam Ajakane et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

, , +15

Identification of Inhibitors of the <i>Leishmania</i> cdc2‐Related Protein Kinase CRK3

Laura A. T. Cleghorn, Andrew Woodland, Iain T. Collie et al. · ChemMedChem · 2011 · 47 citations · Full text

, , +13

From On‐Target to Off‐Target Activity: Identification and Optimisation of <i>Trypanosoma brucei</i> GSK3 Inhibitors and Their Characterisation as Anti‐<i>Trypanosoma brucei</i> Drug Discovery Lead Molecules

Andrew Woodland, Raffaella Grimaldi, Torsten Luksch et al. · ChemMedChem · 2013 · 31 citations · Full text

, , +11

1–5 of 11